BRIEF published on 05/29/2024 at 17:50, 3 months 20 days ago Median Technologies to Attend 2024 ASCO Annual Meeting in Chicago Clinical Trials Oncology Imaging Solutions Median Technologies ASCO Annual Meeting
PRESS RELEASE published on 05/29/2024 at 17:45, 3 months 20 days ago Inside Information / Other news releases Median Technologies to participate in the 2024 ASCO Annual Meeting at McCormick Place, Chicago, IL, USA. Abstract on double reading performance in lung clinical trials. Event details and company overview Clinical Trials Oncology Medical Imaging Median Technologies ASCO Annual Meeting
BRIEF published on 05/21/2024 at 17:50, 3 months 28 days ago Median Technologies strengthens its position with pharmaceutical giants Artificial Intelligence Oncology Medical Imaging Median Technologies Clinical Tests
BRIEF published on 05/21/2024 at 17:50, 3 months 28 days ago Median Technologies renforce sa position auprès des géants pharmaceutiques Imagerie Médicale Intelligence Artificielle Essais Cliniques Oncologie Median Technologies
PRESS RELEASE published on 05/21/2024 at 17:45, 3 months 28 days ago Informations privilégiées / Autres communiqués Median Technologies devient fournisseur privilégié d'un nouveau laboratoire pharmaceutique du Top 3 mondial, renforçant ainsi sa position de leader en services d'imagerie pour les essais cliniques en oncologie Oncologie Median Technologies Laboratoire Pharmaceutique Services D'imagerie Accord-cadre De Services
BRIEF published on 05/10/2024 at 17:50, 4 months 8 days ago Median Technologies Announces Update on Shares Voting Rights Voting Rights Median Technologies Share Structure French Corporate Law Non-voting Shares
BRIEF published on 05/10/2024 at 17:50, 4 months 8 days ago Median Technologies annonce une mise à jour sur les droits de vote des actions Droit De Vote Technologies Médianes Structure De Partage Droit Des Sociétés Français Actions Sans Droit De Vote
PRESS RELEASE published on 05/10/2024 at 17:45, 4 months 8 days ago Modification des droits attachés aux catégories d'actions Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital de Median Technologies au 30 avril 2024, conforme aux réglementations en vigueur Autorité Des Marchés Financiers Capital Droits De Vote Code De Commerce Median Technologies
PRESS RELEASE published on 05/10/2024 at 17:45, 4 months 8 days ago Changes in the rights attaching to the classes of shares or securities Press release about disclosing the total number of voting rights and shares in Median Technologies as of April 30th, 2024 Voting Rights Shares Median Technologies Innovative Imaging Solutions French SME Equity
Published on 09/18/2024 at 23:10, 3 hours 41 minutes ago Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Published on 09/18/2024 at 23:00, 3 hours 51 minutes ago Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Published on 09/18/2024 at 21:15, 5 hours 36 minutes ago New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Published on 09/18/2024 at 21:00, 5 hours 51 minutes ago Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Published on 09/18/2024 at 16:30, 10 hours 21 minutes ago Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
Published on 09/18/2024 at 19:11, 7 hours 39 minutes ago EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Published on 09/18/2024 at 18:45, 8 hours 5 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/18/2024 at 18:31, 8 hours 19 minutes ago EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Published on 09/18/2024 at 18:13, 8 hours 37 minutes ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Published on 09/18/2024 at 17:21, 9 hours 29 minutes ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Published on 09/18/2024 at 18:45, 8 hours 5 minutes ago Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Published on 09/18/2024 at 18:45, 8 hours 5 minutes ago Capital increase following the allocation of free shares to EuropaCorp employees
Published on 09/18/2024 at 17:40, 9 hours 11 minutes ago Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.